Chemed Corporation
CHE
$417.85
$5.551.35%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.85% | 9.79% | 9.23% | 7.38% | 7.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.85% | 9.79% | 9.23% | 7.38% | 7.60% |
| Cost of Revenue | 11.38% | 11.79% | 13.26% | 9.34% | 4.16% |
| Gross Profit | -10.40% | 6.03% | 2.88% | 3.87% | 14.76% |
| SG&A Expenses | -1.89% | -4.48% | 3.80% | 2.39% | 7.65% |
| Depreciation & Amortization | 3.48% | 1.32% | 1.88% | 2.07% | 3.73% |
| Other Operating Expenses | -29.73% | -44.57% | 86.05% | -53.64% | 305.56% |
| Total Operating Expenses | 8.46% | 7.94% | 11.31% | 7.61% | 4.84% |
| Operating Income | -22.74% | 22.00% | 0.59% | 6.11% | 26.79% |
| Income Before Tax | -24.21% | 13.24% | 3.92% | 8.32% | 33.38% |
| Income Tax Expenses | -18.83% | 22.85% | 16.70% | 37.94% | 35.21% |
| Earnings from Continuing Operations | -25.95% | 10.37% | 0.30% | 1.09% | 32.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.95% | 10.37% | 0.30% | 1.09% | 32.80% |
| EBIT | -22.74% | 22.00% | 0.59% | 6.11% | 26.79% |
| EBITDA | -18.77% | 18.50% | 0.93% | 5.50% | 22.66% |
| EPS Basic | -23.38% | 14.13% | 1.96% | 1.43% | 32.46% |
| Normalized Basic EPS | -21.58% | 10.15% | 4.00% | 8.68% | 33.04% |
| EPS Diluted | -23.23% | 14.62% | 2.13% | 1.42% | 32.48% |
| Normalized Diluted EPS | -21.38% | 10.66% | 4.20% | 8.55% | 33.11% |
| Average Basic Shares Outstanding | -3.35% | -3.30% | -1.63% | -0.33% | 0.26% |
| Average Diluted Shares Outstanding | -3.59% | -3.75% | -1.82% | -0.21% | 0.21% |
| Dividend Per Share | 25.00% | 25.00% | 25.00% | 25.00% | 5.26% |
| Payout Ratio | 0.61% | 0.10% | 0.23% | 0.23% | -0.20% |